Short-Term Lamivudine Therapy in Patients with Chronic Hepatitis B

Publisher： Karger

E-ISSN： 1423-0100|46|6|362-366

ISSN： 0300-5526

Source： Intervirology, Vol.46, Iss.6, 2003-12, pp. : 362-366

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Short-Term Lamivudine for the Treatment of Chronic Hepatitis B

By  

Intervirology, Vol. 46, Iss. 6, 2003-12 ,pp. : 367-372

Karger

Access to resources Recommend Favorite

Continued Lamivudine Therapy in Patients with Chronic Hepatitis B

By  

Intervirology, Vol. 46, Iss. 6, 2003-12 ,pp. : 377-387

Karger

Access to resources Recommend Favorite

The Feasibility of Discontinuing Lamivudine in Lamivudine-Resistant Chronic Hepatitis B Patients on Lamivudine and Adefovir Combination Therapy

By  

Intervirology, Vol. 57, Iss. 6, 2014-09 ,pp. : 337-343

Karger

Access to resources Recommend Favorite

Polymerase Domain B Mutation Is Associated with Hepatitis Relapse during Long-Term Lamivudine Therapy for Chronic Hepatitis B

By  

Intervirology, Vol. 48, Iss. 6, 2005-07 ,pp. : 381-388

Karger

Access to resources Recommend Favorite

Long-Term Efficacy of Entecavir Plus Adefovir Combination Therapy versus Entecavir Monotherapy in Adefovir Refractory Chronic Hepatitis B Patients with Prior Lamivudine Resistance

By  

Intervirology, Vol. 57, Iss. 1, 2013-08 ,pp. : 8-16

Karger

Access to resources Recommend Favorite